Experience of using a probiotic containing <i>Lactobacillus reuteri</i> B-9448 in children with acute infectious gastroenteritis-Reference-Cited by-同舟云学术

Experience of using a probiotic containing <i>Lactobacillus reuteri</i> B-9448 in children with acute infectious gastroenteritis

Published:2024-03-26 Issue:1 Volume:2 Page:104-112
ISSN:2949-4664
Container-title:Archives of Pediatrics and Pediatric Surgery
language:
Short-container-title:APPS

Author:

Gorbunov S. G.¹^ORCID,Gonchar N. V.²^ORCID,Bitsueva A. V.³^ORCID

Affiliation:

1. Research Clinical Institute of Childhood of the Moscow Region; “Russian Medical Academy of Continuous Professional Education” of the Ministry of Healthcare of the Russian Federation

2. Children’s Research and Clinical Centre for Infectious Diseases, Federal Medical and Biological Agency of Russia; North-Western State Medical University named after I. I. Mechnikov

3. Research Clinical Institute of Childhood of the Moscow Region; Krasnogorsk City Hospital № 2 of the Ministry of Healthcare of the Moscow region

Abstract

The article presents literature data on the relationship of disorders of the gastrointestinal tract with its microbiota in acute intestinal infections, as well as information on various beneficial properties of the probiotic microorganism Lactobacillus reuteri, including antagonistic effects on pathogenic and opportunistic pathogens, anti-inflammatory and immunomodulatory effects. The clinical and laboratory effectiveness of the use of a probiotic containing the Lactobacillus reuteri B-9448 strain in children with acute infectious gastroenteritis hospitalized. It was found that patients who received this probiotic in complex therapy spent significantly fewer bed days in the hospital compared to children who were not prescribed probiotic. At the same time, no undesirable side effects were registered in the group of patients treated with Lactobacillus reuteri B-9448, which indicates its safety.

Publisher

LLC Global Media Technology

Reference19 articles.

1. Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor) in Moscow [Information on infectious and parasitic diseases for 2022. Form No 2.]. (In Russ.)@@ Svedeniya ob infektsionnykh i parazitarnykh zabolevaniyakh za 2022 g. Forma № 2. Upravlenie Rospotrebnadzora po g. Moskve.

2. Mazankova L.N., Rybalchenko O. V., Nikolayeva I. V. [Microdysbiosis and endogenous infections (a guide for doctors)]. Moscow, 2018, 336 p. (In Russ.)@@ Mazankova L. N., Rybal'chenko O. V., Nikolaeva I. V. Mikrodisbioz i endogennye infektsii (rukovodstvo dlya vrachei). M:. 2018. - C. 336.

3. IPO EASID, Association of Infectious Disease Doctors of St. Petersburg and Leningrad Region. [Rotavirus gastroenteritis in children (clinical recommendations)]. Moscow, 2023, 45 p. (In Russ.)@@ Evro-Aziatskoe obshchestvo po infektsionnym boleznyam, Assotsiatsiya vrachei-infektsionistov Sankt-Peterburga i Leningradskoi oblasti. Rotavirusnyi gastroenterit u detei (klinicheskie rekomendatsii). M:. 2023. -C. 45.

4. Zakharova I.N., Dmitriyeva Yu. A. The intestinal microbiota and use of probiotics from the position of evidence-based medicine. Consilium Medicum. Pediatrics (Suppl.). 2016; 4: 24-28. (In Russ.)@@ Zakharova I. N., Dmitrieva Yu. A. Kishechnaya mikrobiota i primenenie probiotikov s pozitsii dokazatel'noi meditsiny. Consilium Medicum. Pediatriya. 2016; 4: 24-28.

5. Sarra P.G., Dellaglio F., Bottazzi V. Genetic heterogeneity among Lactobacillus acidophilus strains. Syst. Appl. Microbiol. 1985; 6: 86-99.